Edwards Lifesciences EPS - Earnings per Share 2011-2025 | EW
Edwards Lifesciences annual and quarterly earnings per share history from 2011 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Edwards Lifesciences EPS for the quarter ending September 30, 2025 was $0.50, a 90.25% decline year-over-year.
- Edwards Lifesciences EPS for the twelve months ending September 30, 2025 was $2.32, a 66.52% decline year-over-year.
- Edwards Lifesciences 2024 annual EPS was $6.97, a 203.04% increase from 2023.
- Edwards Lifesciences 2023 annual EPS was $2.3, a 5.74% decline from 2022.
- Edwards Lifesciences 2022 annual EPS was $2.44, a 2.52% increase from 2021.
| Edwards Lifesciences Annual EPS | |
|---|---|
| 2024 | $6.97 |
| 2023 | $2.30 |
| 2022 | $2.44 |
| 2021 | $2.38 |
| 2020 | $1.30 |
| 2019 | $1.64 |
| 2018 | $1.13 |
| 2017 | $0.90 |
| 2016 | $0.87 |
| 2015 | $0.75 |
| 2014 | $1.25 |
| 2013 | $0.57 |
| 2012 | $0.41 |
| 2011 | $0.33 |
| 2010 | $0.31 |
| Edwards Lifesciences Quarterly EPS | |
|---|---|
| 2025-09-30 | $0.50 |
| 2025-06-30 | $0.56 |
| 2025-03-31 | $0.61 |
| 2024-12-31 | $0.65 |
| 2024-09-30 | $5.13 |
| 2024-06-30 | $0.61 |
| 2024-03-31 | $0.58 |
| 2023-12-31 | $0.61 |
| 2023-09-30 | $0.63 |
| 2023-06-30 | $0.50 |
| 2023-03-31 | $0.56 |
| 2022-12-31 | $0.65 |
| 2022-09-30 | $0.55 |
| 2022-06-30 | $0.65 |
| 2022-03-31 | $0.59 |
| 2021-12-31 | $0.52 |
| 2021-09-30 | $0.54 |
| 2021-06-30 | $0.78 |
| 2021-03-31 | $0.54 |
| 2020-12-31 | $0.49 |
| 2020-09-30 | $0.52 |
| 2020-06-30 | $-0.20 |
| 2020-03-31 | $0.49 |
| 2019-12-31 | $0.44 |
| 2019-09-30 | $0.43 |
| 2019-06-30 | $0.38 |
| 2019-03-31 | $0.39 |
| 2018-12-31 | $0.02 |
| 2018-09-30 | $0.35 |
| 2018-06-30 | $0.44 |
| 2018-03-31 | $0.32 |
| 2017-12-31 | $0.00 |
| 2017-09-30 | $0.26 |
| 2017-06-30 | $0.29 |
| 2017-03-31 | $0.35 |
| 2016-12-31 | $0.24 |
| 2016-09-30 | $0.22 |
| 2016-06-30 | $0.19 |
| 2016-03-31 | $0.22 |
| 2015-12-31 | $0.21 |
| 2015-09-30 | $0.18 |
| 2015-06-30 | $0.17 |
| 2015-03-31 | $0.19 |
| 2014-12-31 | $0.16 |
| 2014-09-30 | $0.15 |
| 2014-06-30 | $0.85 |
| 2014-03-31 | $0.09 |
| 2013-12-31 | $0.12 |
| 2013-09-30 | $0.11 |
| 2013-06-30 | $0.14 |
| 2013-03-31 | $0.21 |
| 2012-12-31 | $0.13 |
| 2012-09-30 | $0.10 |
| 2012-06-30 | $0.10 |
| 2012-03-31 | $0.09 |
| 2011-12-31 | $0.09 |
| 2011-09-30 | $0.07 |
| 2011-06-30 | $0.08 |
| 2011-03-31 | $0.09 |
| 2010-12-31 | $0.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $49.662B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.924B | 26.25 |
| Intuitive Surgical (ISRG) | United States | $205.210B | 80.29 |
| IDEXX Laboratories (IDXX) | United States | $56.979B | 56.59 |
| Alcon (ALC) | Switzerland | $39.183B | 26.48 |
| IQVIA Holdings (IQV) | United States | $37.616B | 20.98 |
| Mettler-Toledo (MTD) | United States | $29.577B | 34.60 |
| STERIS (STE) | Ireland | $26.302B | 27.15 |
| DexCom (DXCM) | United States | $23.249B | 32.05 |
| Waters (WAT) | United States | $23.062B | 30.50 |
| Hologic (HOLX) | United States | $16.584B | 17.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.430B | 0.00 |
| Globus Medical (GMED) | United States | $11.441B | 23.80 |
| Penumbra (PEN) | United States | $10.977B | 77.21 |
| Masimo (MASI) | United States | $8.046B | 25.78 |
| Sysmex ADR (SSMXY) | Japan | $6.553B | 20.82 |
| Glaukos (GKOS) | United States | $5.319B | 0.00 |
| Teleflex (TFX) | United States | $4.927B | 7.85 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.344B | 38.11 |
| LivaNova (LIVN) | United Kingdom | $3.092B | 16.70 |
| Integer Holdings (ITGR) | United States | $2.436B | 11.43 |
| Artivion (AORT) | United States | $2.256B | 103.54 |
| Nihon Kohden (NHNKY) | Japan | $1.858B | 16.22 |
| Elekta AB (EKTAY) | Sweden | $1.739B | 16.85 |
| PROCEPT BioRobotics (PRCT) | United States | $1.719B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.225B | 0.00 |
| IRadimed (IRMD) | United States | $1.099B | 52.38 |
| Pulse Biosciences (PLSE) | United States | $1.017B | 0.00 |
| OPKO Health (OPK) | United States | $1.013B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.942B | 5.10 |
| SiBone (SIBN) | United States | $0.781B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.604B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.549B | 31.93 |
| Pacific Biosciences Of California (PACB) | United States | $0.525B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.522B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.475B | 0.00 |
| NeuroPace (NPCE) | United States | $0.450B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.441B | 12.18 |
| OrthoPediatrics (KIDS) | United States | $0.426B | 0.00 |
| RxSight (RXST) | United States | $0.412B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.408B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.390B | 2.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.337B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.303B | 50.53 |
| Spectral Diagnostics (EDTXF) | Canada | $0.298B | 0.00 |
| CVRx (CVRX) | United States | $0.250B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.212B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.148B | 0.00 |
| Neuronetics (STIM) | United States | $0.148B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| LENSAR (LNSR) | United States | $0.124B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.075B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.025B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.51 |